Greenwich LifeSciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLSI and other ETFs, options, and stocks.

About GLSI

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

CEO

Snehal S. Patel

CEOSnehal S. Patel

Employees

Employees8

Headquarters

Stafford, Texas

HeadquartersStafford, Texas

Founded

2006

Founded2006

Employees

Employees8

GLSI Key Statistics

Market cap

138.18M

Market cap138.18M

Price-Earnings ratio

-8.64

Price-Earnings ratio-8.64

Dividend yield

—

Dividend yield—

Average volume

108.45K

Average volume108.45K

High today

$10.86

High today$10.86

Low today

$9.71

Low today$9.71

Open price

$9.80

Open price$9.80

Volume

89.89K

Volume89.89K

52 Week high

$18.75

52 Week high$18.75

52 Week low

$8.06

52 Week low$8.06

Greenwich LifeSciences

Why Robinhood?

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX. Show more

GLSI Key Statistics

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.